Turku PET Centre - UTU Research Portal - UTU Research Portal

Go to Header Go to Navigation Go to Content Go to Footer

Turku PET Centre

University of Turku » Independent units

Go to first page

Go to previous page

1 of 9

Go to next page

Go to last page

Go to first page

Go to previous page

208 of 286

Go to next page

Go to last page

Post-target produced [18F]F2 in the production of PET radiopharmaceuticals. (2015)
Pravastatin-induced improvement in coronary reactivity and circulating ATP and ADP levels in young adults with type 1 diabetes (2012)
Prebiopsy multiparametric 3T prostate MRI in patients with elevated PSA, normal digital rectal examination, and no previous biopsy (2015)
Preclinical biodistribution studies of Ga-68-labeled anti-miR15b molecules (2012)
Preclinical development of radiopharmaceuticals for Alzheimer’s disease: Biological evaluation of (S)-[18F]THK5117 and [11C]SMW139 PET tracers in the APP/PS1-21 mouse model of Alzheimer’s disease (2024)
Preclinical evaluation of [18F]SYN1 and [18F]SYN2, novel radiotracers for PET myocardial perfusion imaging (2024)
Preclinical Evaluation of a Humanized Antibody Against Common Lymphatic Endothelial and Vascular Endothelial Receptor-1, 89Zr-Desferrioxamine-Bexmarilimab, in a Rabbit Model of Renal Fibrosis (2022)
Preclinical Evaluation of a Radioiodinated Fully Human Antibody for In Vivo Imaging of Vascular Adhesion Protein-1-Positive Vasculature in Inflammation (2013)
Preclinical evaluation of novel radiopharmaceuticals for positron emission tomography imaging of animal models of multiple sclerosis (2020)
Predicting Anterior Cruciate Ligament Reconstruction Revision Risk (2025)